RIPOR2 Antibody

What is RIPOR2 and what functional roles should researchers consider when selecting antibodies?

RIPOR2 (RHO family interacting cell polarization regulator 2) is a multifunctional protein with significant roles in several cellular processes. In humans, the canonical protein consists of 1068 amino acid residues with a molecular weight of 118.5 kDa . Its subcellular localization is primarily in the cell membrane and cytoplasm . Researchers should be aware that RIPOR2:

• Acts as an inhibitor of the small GTPase RHOA

• Plays crucial roles in regulating myoblast and hair cell differentiation

• Influences lymphocyte T proliferation and neutrophil polarization

• Is involved in mechanosensory hair cell function and normal hearing development

• Has been identified as having two main isoforms

When selecting antibodies, researchers should consider which domain or epitope is most relevant to their specific research question, as different antibodies may target different regions of the protein.

What are the most common applications for RIPOR2 antibodies in research settings?

Based on current research applications, RIPOR2 antibodies are primarily utilized in the following techniques:

Researchers should verify the specific application validation for their selected antibody, as not all antibodies work equally well across all applications .

What species reactivity is available for RIPOR2 antibodies and what are the implications for cross-species studies?

RIPOR2 antibodies are available with reactivity to multiple species, though human-reactive antibodies are most common. The search results indicate:

• Human-reactive antibodies are most widely available

• Mouse and rat-reactive antibodies are also common

• Zebrafish-reactive antibodies have been developed for developmental studies

• RIPOR2 gene orthologs have been reported in mouse, rat, bovine, frog, zebrafish, chimpanzee, and chicken species

When conducting cross-species studies, researchers should be aware that while RIPOR2 is conserved across many species, epitope conservation may vary. Antibodies raised against human RIPOR2 might not recognize the orthologous proteins in all species with equal affinity. Validation in each target species is recommended before proceeding with experiments .

What are the optimal conditions for immunohistochemistry (IHC) using RIPOR2 antibodies?

For optimal IHC results with RIPOR2 antibodies, researchers should follow these evidence-based protocols:

• Tissue preparation: Use formalin-fixed, paraffin-embedded tissue sections for reliable results

• Antigen retrieval: Implement tissue microwave antigen retrieval prior to antibody application

• Primary antibody incubation:

  • Concentration: Use at 1:20-1:200 dilution (depending on specific antibody)

  • Temperature: Incubate overnight at 4°C

• Secondary antibody: Incubate for approximately 1 hour at room temperature

• Detection system: The Rabbit IgG mini-PLUS Kit has been successfully used to detect and visualize the DAB complex, with hematoxylin counterstaining for nuclei

• Controls: Include both positive and negative controls to ensure specificity

This protocol has been validated in recent cervical cancer tissue studies, demonstrating effective detection of RIPOR2 in clinical samples .

How should researchers approach Western blot protocols for RIPOR2 detection?

For optimal Western blot detection of RIPOR2, researchers should consider:

• Sample preparation:

  • Extract total protein from cells or tissues using standard lysis buffers

  • Include protease inhibitors to prevent degradation

  • Use fresh samples when possible to maintain protein integrity

• Gel electrophoresis:

  • Use 8-10% SDS-PAGE gels due to RIPOR2's high molecular weight (118.5 kDa)

  • Load adequate protein (25-50 μg) for clear detection

• Antibody conditions:

  • Primary antibody: Dilute 1:500-1:2000 in blocking buffer

  • Incubation: Overnight at 4°C for optimal binding

  • Secondary antibody: Use HRP-conjugated anti-rabbit IgG (most RIPOR2 antibodies are rabbit-derived)

• Detection:

  • Enhanced chemiluminescence (ECL) is suitable for most applications

  • Longer exposure times may be needed due to variable expression levels

• Verification:

  • Confirm band size at approximately 118.5 kDa for full-length RIPOR2

  • Be aware that post-translational modifications may affect migration

These recommendations are derived from published research that successfully detected RIPOR2 protein expression in experimental settings .

How can RIPOR2 antibodies be used to investigate its role in cancer biology and immunotherapy response?

Recent studies have identified RIPOR2 as a potential biomarker in cancer research, particularly in cervical cancer. Researchers can utilize RIPOR2 antibodies to:

Research by Xing et al. (2022) demonstrated that RIPOR2 overexpression inhibited proliferation and migration of cervical cancer cells (SiHa and HeLa), suggesting tumor-suppressive functions .

What approaches can be used to study RIPOR2's interaction with DNA damage response (DDR) pathways?

RIPOR2 has been linked to genomic instability and DNA damage response pathways. Researchers can use RIPOR2 antibodies to investigate these interactions through:

• Co-immunoprecipitation (Co-IP) studies:

  • Use RIPOR2 antibodies to pull down protein complexes

  • Analyze interacting DDR proteins such as PARP1, FEN1, PARP2, and ATM

• Immunofluorescence co-localization:

  • Co-stain for RIPOR2 and DDR proteins

  • Assess co-localization before and after DNA damage induction

• Chromatin immunoprecipitation (ChIP):

  • Investigate if RIPOR2 associates with chromatin in response to DNA damage

• Functional validation:

  • Monitor DDR protein expression after RIPOR2 modulation

  • Recent research showed that PARP1 protein levels were significantly higher in RIPOR2-overexpression cells

  • FEN1, PARP2, and RAD52 were negatively correlated with RIPOR2 expression

These approaches have revealed that RIPOR2 expression correlates with expression patterns of several DDR-related genes, with particularly strong relationships to PARP1, suggesting potential therapeutic implications for PARP inhibitors in cancer treatment .

How can researchers validate the specificity of their RIPOR2 antibodies?

Ensuring antibody specificity is critical for reliable results. Researchers should implement comprehensive validation strategies:

• Positive and negative controls:

  • Positive control: Tissues or cells known to express RIPOR2 (e.g., primary fetal mononuclear myoblasts)

  • Negative control: Use isotype control antibodies or samples with RIPOR2 knockdown

• Competitive blocking:

  • Pre-incubate antibody with immunizing peptide before application

  • Signal should be significantly reduced if antibody is specific

  • This approach was demonstrated in GFP-RIPOR2 binding studies

• Genetic validation:

  • Use RIPOR2 knockout or knockdown cells

  • Compare with overexpression systems

  • The signal should correlate with expression levels

• Multiple antibody approach:

  • Use different antibodies targeting different RIPOR2 epitopes

  • Results should be consistent across antibodies

• Western blot verification:

  • Confirm single band at expected molecular weight (118.5 kDa)

  • Multiple bands may indicate isoforms, degradation, or non-specificity

Independent validation is particularly important as RIPOR2 has multiple synonyms (DFNA21, DFNB104, DIFF40, DIFF48, FAM65B, MYONAP, PL48, and C6orf32) , which may lead to confusion in antibody targeting and specificity.

How can RIPOR2 antibodies be applied to investigate its role in hereditary hearing loss?

RIPOR2 has been implicated in both autosomal dominant (DFNA21) and autosomal recessive (DFNB104) forms of hearing loss . Researchers investigating these connections can employ RIPOR2 antibodies through:

• Immunohistochemistry of cochlear tissues:

  • Study expression patterns in inner ear structures

  • Compare RIPOR2 localization between normal and hearing-impaired samples

  • Assess stereocilia development and maintenance in hair cells

• Analysis of RIPOR2 variants:

  • Compare wild-type and mutant RIPOR2 expression using antibodies that recognize both forms

  • For the c.1696_1707del variant, use antibodies that don't target this specific region

• Functional studies in cellular models:

  • Investigate RIPOR2's interaction with other proteins involved in hair cell stereocilia development

  • Studies indicate RIPOR2 is "required for normal development of inner and outer hair cell stereocilia within the cochlea of the inner ear"

• Protein-protein interaction studies:

  • Investigate interactions with known hearing loss proteins

  • Use co-immunoprecipitation followed by Western blot detection

Recent research has identified a RIPOR2 in-frame deletion (c.1696_1707del) as a frequent and highly penetrant cause of adult-onset progressive hearing loss , making this protein a significant target for hearing loss research.

What methods can be used to study RIPOR2's interaction with small molecules like gentamicin in hearing-related research?

Research has revealed that RIPOR2 interacts with gentamicin (GEN), which is relevant to aminoglycoside-induced hearing loss. To study these interactions, researchers can use:

• Pull-down assays with GEN-conjugated beads:

  • Use RIPOR2 antibodies to detect pulled-down protein

  • Include competitive soluble GEN controls

  • This approach confirmed direct binding between GEN and RIPOR2

• Immunofluorescence co-localization studies:

  • Visualize distribution of RIPOR2 in inner ear cells after GEN exposure

  • Assess potential relocalization of RIPOR2 following GEN treatment

• Autophagy pathway investigation:

  • Research suggests RIPOR2-mediated autophagic dysfunction is involved in aminoglycoside-induced hearing loss

  • Use RIPOR2 antibodies alongside autophagy markers to study this pathway

• Overexpression and knockout studies:

  • Express GFP-tagged RIPOR2 to study GEN binding

  • Use RIPOR2 antibodies to confirm expression levels

  • GFP-RIPOR2 has been successfully captured using GEN-conjugated beads

These approaches can help elucidate the mechanisms by which aminoglycosides induce hearing loss through interaction with RIPOR2, potentially leading to therapeutic interventions to prevent this side effect.

What are common challenges when using RIPOR2 antibodies and how can they be addressed?

Researchers may encounter several challenges when working with RIPOR2 antibodies:

• High molecular weight detection issues:

  • Problem: Incomplete transfer during Western blotting due to RIPOR2's large size (118.5 kDa)

  • Solution: Use lower percentage gels (8%), extend transfer time, or implement wet transfer methods

• Multiple band detection:

  • Problem: Detection of multiple bands due to isoforms or degradation

  • Solution: Use fresh samples, include protease inhibitors, and verify which isoform(s) your antibody targets

• Cross-reactivity with RIPOR paralogs:

  • Problem: Potential cross-reactivity with RIPOR1, an important paralog of RIPOR2

  • Solution: Use epitope-specific antibodies that target unique regions of RIPOR2

• Synonym confusion:

  • Problem: RIPOR2 has multiple synonyms (FAM65B, DFNA21, etc.) which can lead to antibody selection confusion

  • Solution: Verify target specificity by checking the immunogen sequence against current RIPOR2 sequence data

• Variability in immunohistochemistry results:

  • Problem: Inconsistent staining patterns

  • Solution: Optimize antigen retrieval methods and antibody dilutions; validated protocols suggest 1:20-1:200 dilution range for IHC

These solutions are based on documented research practices and product recommendations from various antibody suppliers .

How can researchers optimize immunofluorescence protocols for RIPOR2 detection in different cell types?

For optimal immunofluorescence detection of RIPOR2 across different cell types, researchers should consider:

• Cell-type specific optimization:

  • T lymphocytes: RIPOR2 is involved in chemokine-induced responses , requiring gentler fixation methods

  • Myoblasts: RIPOR2 promotes filopodia formation , suggesting membrane preservation is critical

  • Hair cells: RIPOR2 localizes to stereocilia base , requiring specialized cochlear preparation methods

• Validated protocol elements:

  • Fixation: 4% paraformaldehyde for 15-20 minutes at room temperature

  • Permeabilization: 0.2% Triton X-100 for 10 minutes

  • Blocking: 2-hour room temperature incubation

  • Primary antibody: 1:50-1:200 dilution, overnight at 4°C

  • Secondary antibody: Alexa-647 goat anti-rabbit (1:500) for 2 hours at room temperature

  • Nuclear counterstain: DAPI for 10 minutes

• Co-localization studies:

  • For membrane co-localization: Include membrane markers

  • For cytoskeletal studies: Co-stain with actin markers

  • For immune cell studies: Include appropriate immune cell markers

• Imaging recommendations:

  • Use confocal microscopy for precise subcellular localization

  • Z-stack imaging for complete cellular distribution analysis

This approach has been successfully implemented in recent studies investigating RIPOR2 localization in cervical cancer tissues .